Cengild debuts on ACE Market at 50% premium of 49.5 sen a share

L to R: Emeritus Professor Datuk Goh Khean Lee, Executive Director, Cengild Medical Bhd; Lee Jim Leng, Group Managing Director/CEO, Hong Leong Investment Bank Bhd, Datuk Tan Huck Joo, Executive Chairman, Cengild Medical; Chong Su-Lin, Independent Non-Executive Director, Cengild Medical; Lily Yap, CEO, Cengild Medical; Mohamed Akhtar Mohamed Ditali Qureshi, Executive Director, Cengild Medical; and Azrina Abu Bakar, Independent Non-Executive Director, Cengild Medical

KUALA LUMPUR: Cengild Medical Bhd made its debut on the ACE Market of Bursa Malaysia today at 49.5 sen a share, a 50% premium to its issue price of 33 sen.

"Cengild has travelled through a remarkable journey since October 2017 and this IPO has provided us with the platform to realize our ambitions and accelerate our expansion plans.